Home Healthcare Pharmaceuticals Subcutaneous Biologic Market

Subcutaneous Biologic Market Size, Share & Trends Analysis Report By Molecule Class (Monoclonal Antibodies, Peptides/Proteins, Immunoglobulins, Cytokines, Oligonucleotides, Enzymes/Hormones, Others), By Delivery System (Prefilled Syringes, Autoinjector Pens, Wearable Injectors, Vial & Syringes, Prefilled Cartridges for Pens), By Therapy Area (Metabolics, Autoimmune & Inflammatory, Oncology & Hematology, Neurology, Respiratory & Allergy, Rare Diseases & Immunodeficiencies, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 17, 2026 | Author: Dhanashri B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Subcutaneous Biologic Market, By Molecule Class 2022-2034 (USD MILLION/ Units)
    1. Monoclonal Antibodies
    2. Peptides/Proteins
    3. Immunoglobulins
    4. Cytokines
    5. Oligonucleotides
    6. Enzymes/Hormones
    7. Others
  2. Subcutaneous Biologic Market, By Delivery System 2022-2034 (USD MILLION/ Units)
    1. Prefilled Syringes
    2. Autoinjector Pens
    3. Wearable Injectors
    4. Vial & Syringes
    5. Prefilled Cartridges for Pens
  3. Subcutaneous Biologic Market, By Therapy Area 2022-2034 (USD MILLION/ Units)
    1. Metabolics
    2. Autoimmune & Inflammatory
    3. Oncology & Hematology
    4. Neurology
    5. Respiratory & Allergy
    6. Rare Diseases & Immunodeficiencies
    7. Others
  4. Regional Subcutaneous Biologic Market
    1. North America
      1. North America Subcutaneous Biologic Market By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      2. North America Subcutaneous Biologic Market By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      3. North America Subcutaneous Biologic Market By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
      4. U.S.
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      5. Canada
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
    2. Europe
      1. Europe Subcutaneous Biologic Market By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      2. Europe Subcutaneous Biologic Market By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      3. Europe Subcutaneous Biologic Market By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
      4. U.K.
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      5. Germany
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      6. France
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      7. Spain
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      8. Italy
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      9. Russia
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      10. Nordic
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      11. Benelux
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      12. Rest of Europe
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
    3. APAC
      1. APAC Subcutaneous Biologic Market By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      2. APAC Subcutaneous Biologic Market By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      3. APAC Subcutaneous Biologic Market By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
      4. China
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      5. Korea
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      6. Japan
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      7. India
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      8. Australia
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      9. Taiwan
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      10. South East Asia
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      11. Rest of Asia-Pacific
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
    4. Middle East and Africa
      1. Middle East and Africa Subcutaneous Biologic Market By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      2. Middle East and Africa Subcutaneous Biologic Market By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      3. Middle East and Africa Subcutaneous Biologic Market By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
      4. UAE
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      5. Turkey
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      6. Saudi Arabia
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      7. South Africa
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      8. Egypt
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      9. Nigeria
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      10. Rest of MEA
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
    5. LATAM
      1. LATAM Subcutaneous Biologic Market By Molecule Class 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
      2. LATAM Subcutaneous Biologic Market By Delivery System 2022-2034 (USD MILLION/ Units)
        1. Prefilled Syringes
        2. Autoinjector Pens
        3. Wearable Injectors
        4. Vial & Syringes
        5. Prefilled Cartridges for Pens
      3. LATAM Subcutaneous Biologic Market By Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Metabolics
        2. Autoimmune & Inflammatory
        3. Oncology & Hematology
        4. Neurology
        5. Respiratory & Allergy
        6. Rare Diseases & Immunodeficiencies
        7. Others
      4. Brazil
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      5. Mexico
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      6. Argentina
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      7. Chile
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      8. Colombia
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
      9. Rest of LATAM
        1. Monoclonal Antibodies
        2. Peptides/Proteins
        3. Immunoglobulins
        4. Cytokines
        5. Oligonucleotides
        6. Enzymes/Hormones
        7. Others
        8. Prefilled Syringes
        9. Autoinjector Pens
        10. Wearable Injectors
        11. Vial & Syringes
        12. Prefilled Cartridges for Pens
        13. Metabolics
        14. Autoimmune & Inflammatory
        15. Oncology & Hematology
        16. Neurology
        17. Respiratory & Allergy
        18. Rare Diseases & Immunodeficiencies
        19. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.